Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
22
Number of overlapping holdings
46.8%
% of CANC's 47 holdings also in CNCR
30.6%
% of CNCR's 72 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 3.6% | 2.0% | 2.0% |
|
BLUEPRINT MEDICINES CORP. | 4.6% | 1.7% | 1.7% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.4% | 1.7% | 1.7% |
|
SCHRODINGER, INC. | 2.0% | 1.7% | 1.7% |
|
REVOLUTION MEDICINES, INC. | 4.2% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to CNCR
 |
ASTRAZENECA PLC | 5.6% |
|
GILEAD SCIENCES INC | 5.3% |
 |
ARGENX SE ADR | 4.6% |
|
INCYTE CORP | 4.3% |
|
ILLUMINA INC | 4.2% |
|
REGENERON PHARMACEUTICALS | 4.0% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.6% |
|
DAIICHI SANKYO CO LTD | 3.0% |
|
BLUEPRINT MEDICINES CORP. | 2.9% |
|
REVOLUTION MEDICINES, INC. | 2.6% |
CANC Underweight Relative to CNCR
|
RECURSION PHARMACEUTICALS, INC CLASS | -3.3% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -2.4% |
|
MONTE ROSA THERAPEUTICS, INC. | -2.1% |
|
REPLIMUNE GROUP, INC. | -1.9% |
|
XENCOR INC | -1.8% |
|
BRISTOL-MYERS SQUIBB CO | -1.8% |
|
MERSANA THERAPEUTICS, INC. | -1.7% |
|
ENLIVEN THERAPEUTICS, INC. | -1.6% |
|
ZYMEWORKS INC. | -1.6% |
|
VOR BIOPHARMA, INC. | -1.6% |